Drugs / QTP104
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05876364 | Nov 2021 → Jun 2022 | COVID-19 | Quratis Inc. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | QTP104 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05876364 ↗ |
| Route | Intramuscular | “Intramuscular injections” NCT05876364 ↗ |